Prelude Capital Management, LLC Wave Life Sciences Ltd. Call Options Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$8.49 - $19.54 $13,584 - $31,264
-1,600 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$7.44 - $11.29 $11,904 - $18,064
1,600 New
1,600 $17,000
Q1 2020

May 15, 2020
SELL
$6.94 - $14.22 $8,328 - $17,064
-1,200 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$7.99 - $37.6 $9,588 - $45,120
1,200 New
1,200 $10,000

Others Institutions Holding WVE

# of Institutions
168
Shares Held
117M
Call Options Held
148K
Put Options Held
109K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.06B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email